Cxbladder is a non-invasive test for the detection of bladder cancer that gives you actionable results that can make a meaningful difference in your patient's treatment.
The Cxbladder technology comprises proprietary, accurate molecular testing of genomic biomarkers (mRNA) from a small volume of patients’ urine, and patient clinical characteristics enabling the non-invasive detection of bladder and other urinary tract cancers (urothelial carcinoma).
The Cxbladder suite of products provides a ‘one-stop shop’ for clinicians in the primary detection and post-treatment management of urothelial carcinoma (UC).
Comprehensive solution for your clinical needs
Cxbladder gives you actionable results that can make a meaningful difference in your patient’s diagnosis and treatment.Learn more about Cxbladder’s clinical applications
Cxbladder sampling process
Cxbladder is a suite of non-invasive tests that is easy and straightforward to use.Watch the instructional video here
Talk to a Rep
Contact us by phone or email, or fill out an online form and a Cxbladder representative will get back to you.Complete an information request form today